Cl. Rock et al., RESPONSIVENESS OF CAROTENOIDS TO A HIGH VEGETABLE DIET INTERVENTION DESIGNED TO PREVENT BREAST-CANCER RECURRENCE, Cancer epidemiology, biomarkers & prevention, 6(8), 1997, pp. 617-623
Epidemiological studies suggest that a high vegetable diet may reduce
risk for breast cancer and may also improve prognosis after the diagno
sis of breast cancer. Circulating carotenoids may serve as a biomarker
of vegetable and fruit intake, although several factors affect their
bioavailability from food sources and may influence concentrations. On
e purpose of this study was to identify factors predictive of serum ca
rotenoid, retinol, and alpha-tocopherol concentrations in 79 postsurgi
cally resected breast cancer patients at enrollment and at 12 months i
n a feasibility study of a high vegetable, low fat diet intervention t
o reduce risk for cancer recurrence. Another purpose was to identify v
ariables associated with change in these serum concentrations 12 month
s after randomization into control and intervention groups. The diet i
ntervention (versus control) group had significantly greater increases
in carotenoid intakes (P < 0.03) and significantly greater increases
in serum concentrations of lutein, alpha- and beta-carotene, lycopene,
and retinol (P < 0.04). Stepwise multiple regression revealed the lev
el of dietary intake to be predictive of most serum carotenoid concent
rations at baseline and 12 months, with additional associations betwee
n selected micronutrient concentrations and serum cholesterol, body ma
ss index, age, percentage of energy intake from fat, and alcohol intak
e also observed at these time points. Intervention group change in ser
um carotenoid concentrations was inversely associated with baseline le
vel, age, and change in serum cholesterol concentration and positively
associated with change in carotenoid and alcohol intake. Circulating
carotenoid concentrations are responsive to a high vegetable diet inte
rvention, which also included reduced dietary fat and increased fiber
intakes, to reduce risk for breast cancer recurrence.